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INTRODUCTION
Acute renal failure (ARF) is defined as a deteriora-
tion of renal function over a period of hours to days, and
up to 20 per cent of cases can be directly attributed to
drugs.1,2
ARF can be classified as prerenal, postrenal and re-
nal. It is of critical importance to classify renal failure
into one of these categories as promptly as possible, since
diagnostic and therapeutic management designed to re-
serve its course depends upon recognition of  etiologic
and pathogenic mechanisms.
Toxic nephropathy refers to adverse effects upon kid-
neys by agents encountered in ordinary life or agents
used for diagnostic or therapeutics purposes in the prac-
tise of medicine. Reasons for renal susceptibility to tox-
icity are its large surface area, high blood flow, and role
in the detoxifications and excretion of most drugs.
Chronic damage occurs  insidiously and the role of drugs
may to unrecognized 4,5
Over 50 drugs have been reported as causes of acute
interstitial nephritis (AIN), including penicilins,
sulphonamides, NSAID. Other drugs that are well rec-
ognized as causes of this condition include ciprofloxacin,
rifampicin, phenytoin and cephalosporins. The underly-
ing immunological mechanism remains to be elucidated.
The diagnostic, within 2-4 weeks after drugs exposure.
Renal biopsy remains the most definitive test. The key
to diagnosis and treatment of drug related renal syndrome
is generally dependent on early recognition of and dis-
continuing the action of the offending agent.6,7
Rifampicin is rapidly eliminated in the bile,and
enterohepatic circulation. The half-life of rifampicin is
progressively shortened by about 40% during the first
14 days of treatment, owing to induction of hepatic mi-
crosomal enzymes with acceleration of deacetylation of
the drugs. Up to 30% of a dose of the drugs is secreted
in the urine.8-10
In general, rifampicin is a well-tolerated drug.
Asymptomatic transaminase elevation may occur during
the first few weeks of therapy. However the incidence
of overt hepatitis is less than 1 percent.
Other adverse effects of rifampicin such as allergic
reaction, drug fever, hemolytic anemia, renal insufficiency
and acute renal failure have been observed rarely.
Acute Intertitial Nephritis (AIN) occurs as an immuno
allergic or cell-mediated immune response to a variety
of drugs, particularly penicilin, rifampicin, etc. Both hu-
moral and cellural immunity are involved.2,3
Drug-related hepatotoxicity should always be con-
sidered in the differential diagnosis of dysfunction. The
clinical picture may be that of hepatocellar (hepatitis like)
injury, cholestasis, or both vascular lesions or tumor of
the liver. All of these may be caused by drugs or toxins.
Liver enzymes generally return to normal within a few
weeks after withdrawal of the offending agent.
CASE REPORT
A thirty three-year-old man was admitted to Cipto
Mangunkusumo Hospital because of fever and weak-
ness. Ten days prior to admission, the patient suffered
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from bloody cough of about one tea spoon, prolonged
cough and night sweat. At that time, he came to a gen-
eral practitioner and he had a chest X-ray performed.
The doctor said that he had lung tuberculosis and he
received two kinds of drugs: rifampicin (450 mg) and
vitamin. The next day, the patient felt more weakness,
and suffered from nausea and vomitting. The patient
continued on these drugs for 5 days. Two days after
that, he complained that his urine color was red and that
his eyes were yellow. This condition brought him to come
to the hospital.
In past history of illness, on 1984, he suferred Pulmo-
nary TB and received streptomycin injections for three
months and oral drugs for one year. After that, the doc-
tor said that he was already well.
On initial examination, the patient was fully alert and
moderately ill. His body weight was 60 kg, and his height
was 165 cm. The blood pressure was 120/80 mmHg.
The pulse was 90x/m, the respiratory rate was 22x/m.
The conjunctivae was not pale, the sclera was icteric.
The chest examination showed no abnormality. From the
abdominal examination, we found liver enlargement with-
out palpable pain. The spleen was not palpable and there
was no ascites. No enlargement of lymph nodes.
Laboratoric studies were performed (tables 1). The
chest X-rays revealed a specific active process with left
pleural reaction.
Further laboratoric examination showed that rifampi-
cin antibody was negative and all serological hepatitis
was negative. The acid fast bacilli sputum was negative
for three times.
On the follow up, rifampicin was discontinoued. Due
to a lack of urine production, the patient was given furo-
semide injection for a few days. This injection improved
urine production. Jaundice in this patient decreased and
disappeared after 7 days. The evaluation of lung TB
showed that patient had no active lung TB.
DISCUSSION
Drug induced hepatitis is a potential complication, be-
cause the liver is central for metabolic disposition of all
drug.11 Injury to hepatocytes result in the disruption of
intracelluler function or membrane integrity. Rifampicin
is one of several drugs that can cause drug induced hepa-
titis. Rifampicin can impair bilirubin uptake, resulting in
elevated bilirubin levels.
In this case, we can see rifampicin induced hepatitis
and increased bilirubin level of patient up to 7,4 mg/dl.
Actually hepatitis from rifampicin rarely occurs in pa-
tient with normal liver function. There was no data of
the patient’s liver function prior to drug administation.
Besides inducing hepatitis, rifampicin can induce
acute renal failure as well. This drug can cause  acute
interstitial nephritis. But renal failure due to acute inter-
stitial nephritis is often reversible after withdrawal of
treatment. In this case, renal function went back to nor-
mal after withdrawal of rifampicin.6 Actually, corticos-
teroids can be used to induce recovery of renal function,
but its use is still controversial. In this case, we did not
administer corticosteroids and the patient’s renal func-
tion recovered just only by terminating drug administra-
tion.
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Table 1. Hematological and blood chemical values 
VARIABLE On admission 
Hemoglobin (g%) 12.2 
Hematocrit (%) 33 
White-cell count (per mm3) 17 400 
Platelet count (per mm3) 123 000 
Blood sugar (mg/dl) 99 
Bilirubin (mg/dl)Total 
Conjugated 
7.4 
3.9 
Protein 
Albumin 
Globulin 
 
7.4 
5.5 
Alkaline phosphatase (U/liter) 240 
SGOT (U/l) 88 
SGPT (U/l) 110 
Ureum (mg/dl) 219 
Creatinine (mg/dl) 12.8 
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